Serina Therapeutics Inc (SER)
9.191
0.00 (0.00%)
USD |
NYAM |
Apr 26, 16:00
Serina Therapeutics Total Liabilities (Quarterly): 45.02M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 45.02M |
| June 30, 2023 | 45.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 38.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.64M
Minimum
Dec 2022
45.02M
Maximum
Jun 2023
42.90M
Average
45.02M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.739M |
| Shareholders Equity (Quarterly) | -35.29M |